 Corsitin, QUE, has been shown to have excellent anti-inflammatory, anti-oxidant, anti-microbial, and wound healing properties, making it a promising candidate for the development of novel treatments for diabetic wound infections. In this study, researchers developed polylactic acids slash poly, vinyl pyrrolidone, PP, co-electrospun fibers loaded with QUE as a drug delivery system for the treatment of diabetic wound infections. The results showed that these fibers had a bimodal diameter distribution with contact angles ranging from 120 degrees to 127 degrees and then decreasing to 0 degrees within 5 seconds, indicating their hydrophilicity. Additionally, the QUE-loaded PP fibers released QUE at a steady rate over time in simulated wound fluid SWF. This resulted in a significant reduction in the expression of pro-inflammatory genes TNF-alpha and IL1-beta in macrophase cells, suggesting that QUE may be useful in reducing inflammation associated with diabetic wound infections. This article was authored by Francesca DeCristo, Anna Valentino, Alenia DeLuca, and others.